Charlottesville, VIRGINIA3 Active Studies

Pulmonary Embolism Clinical Trials in Charlottesville, VIRGINIA

Find 3 actively recruiting pulmonary embolism clinical trials in Charlottesville, VIRGINIA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
266
Enrolling

Recruiting Pulmonary Embolism Studies in Charlottesville

About Pulmonary Embolism Clinical Trials in Charlottesville

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 3 pulmonary embolism clinical trials recruiting participants in Charlottesville, VIRGINIA. These studies are seeking a combined 266 participants. Research is being sponsored by Emory University, Elizabeth Austen Lawson, University of Virginia. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Charlottesville — FAQ

Are there pulmonary embolism clinical trials in Charlottesville?

Yes, there are 3 pulmonary embolism clinical trials currently recruiting in Charlottesville, VIRGINIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Charlottesville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Charlottesville research site will contact you about next steps.

Are clinical trials in Charlottesville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Charlottesville studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 3 active trials in Charlottesville are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated March 2, 2026 from ClinicalTrials.gov